The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) |
93.279 |
PAR-21-183 |
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-009 |
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-010 |
Recompetition of the Pediatric Scientist Development Program (PSDP) (K12 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-22-006 |
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.273, 93.279, 93.286, 93.361, 93.398, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867 |
PAR-21-173 |
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.273, 93.279, 93.286, 93.361, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867 |
PAR-21-169 |
Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional) |
93.847 |
RFA-DK-20-034 |
Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed |
93.846 |
RFA-AR-22-002 |
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) |
93.393 |
PAR-21-061 |
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) |
93.242 |
PAR-21-176 |
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) |
93.242 |
PAR-21-175 |
Research on Bat Immunology (R21 Clinical Trial Not Allowed) |
93.855 |
PAR-21-184 |
High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional) |
93.866 |
RFA-AG-22-013 |
High-Priority Behavioral and Social Research Networks in Alzheimers Disease and Alzheimers Disease-Related Dementias (R24 Clinical Trial Optional) |
93.866 |
RFA-AG-22-012 |
The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) |
93.847, 93.855 |
RFA-DK-21-004 |
Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-020 |
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-021 |
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-035 |
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
93.351 |
PAR-21-167 |
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) |
93.242 |
PA-21-195 |
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) |
93.242 |
PA-21-194 |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) |
93.398 |
PAR-21-128 |
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed) |
93.113 |
PAR-21-172 |
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required) |
93.113 |
PAR-21-170 |
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed) |
93.113, 93.213, 93.242, 93.273, 93.279, 93.313, 93.398, 93.847, 93.865, 93.867 |
RFA-OD-21-005 |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) |
93.398 |
PAR-21-111 |
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required) |
93.113 |
PAR-21-171 |
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) |
93.398 |
PAR-21-318 |
Medical Scientist Training Program (T32) |
93.859 |
PAR-21-189 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) |
93.853 |
PAR-21-122 |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
93.393, 93.399 |
PAR-21-190 |
BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-21-130 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) |
93.853 |
PAR-21-123 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) |
93.213, 93.853 |
PAR-21-124 |
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) |
93.307 |
RFA-MD-21-006 |
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) |
93.307 |
RFA-MD-21-005 |
HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed) |
93.121, 93.213, 93.242, 93.273, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-21-016 |
HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) |
93.121, 93.213, 93.242, 93.273, 93.350, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-21-015 |
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
PAR-21-163 |
DoD Gulf War Illness, Therapeutic/Biomarker Trial Award |
12.420 |
W81XWH-21-GWIRP-TBTA |
Search Results 2241-2280 of 14606 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |